TFFP — TFF Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $5.14m
- $1.93m
- $0.73m
Annual cashflow statement for TFF Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11.9 | -18.6 | -31 | -31.8 | -21.2 |
| Depreciation | |||||
| Non-Cash Items | 0.59 | 2.21 | 2.97 | 4.59 | 3.67 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.064 | -0.26 | -1.6 | -0.551 | 1.03 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -11.2 | -16.6 | -29.6 | -27.3 | -16 |
| Capital Expenditures | — | -1.1 | -0.869 | -1.55 | -0.095 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -1.1 | -0.869 | -1.55 | -0.095 |
| Financing Cash Flow Items | 0 | — | — | — | -0.109 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 29 | 25 | 28.9 | 11.8 | 5.01 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.8 | 7.21 | -1.51 | -17.2 | -11.1 |